mofezolac has been researched along with Body Weight in 3 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mofezolac also has a potent inhibitory activity on the algesic responses induced by the mechanical stimulus of the inflammed tissue." | 1.28 | [Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug]. ( Miyake, H; Ono, N; Sunami, A; Yamamoto, N; Yamasaki, Y, 1990) |
| "Mofezolac (N-22) is a newly developed analgesic and anti-inflammatory agent." | 1.28 | Acute toxicity tests of mofezolac (N-22) in mice and rats. ( Ichiki, T; Kodama, R; Kuwasaki, E; Kuwata, M; Satoh, K; Sone, H; Yamamoto, N; Yamashita, K, 1990) |
| "Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent." | 1.28 | [Three-month subacute oral toxicity study of mofezolac (N-22) in dogs]. ( Iwata, M; Kiguchi, M; Nasu, Y; Shimpo, K; Takeuchi, M; Yada, H; Yamashita, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, N | 1 |
| Yamamoto, N | 2 |
| Sunami, A | 1 |
| Yamasaki, Y | 1 |
| Miyake, H | 1 |
| Satoh, K | 1 |
| Kuwasaki, E | 1 |
| Ichiki, T | 1 |
| Sone, H | 1 |
| Kodama, R | 1 |
| Kuwata, M | 1 |
| Yamashita, K | 2 |
| Shimpo, K | 1 |
| Takeuchi, M | 1 |
| Kiguchi, M | 1 |
| Iwata, M | 1 |
| Nasu, Y | 1 |
| Yada, H | 1 |
3 other studies available for mofezolac and Body Weight
| Article | Year |
|---|---|
[Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug].
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Body Weight; | 1990 |
Acute toxicity tests of mofezolac (N-22) in mice and rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Female; Gastroi | 1990 |
[Three-month subacute oral toxicity study of mofezolac (N-22) in dogs].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Body Weight; | 1990 |